Chemed
CHE
501.45
-8.39
-1.65%
Chemed
US · CHE
#1837 by market cap
Listed 1970
501.45
-8.39
-1.65%
Live - 5344 symbols - heartbeat 337s ago
· 2026-10-08 07:24
Pre-market
499.59
-0.37%
After-hours
501.50
+0.01%
- Market cap
- 6.53B
- P/E (TTM)i
- 25.22
- P/Bi
- 7.86
- EPSi
- 18.34
- Div yieldi
- 0.48%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on CHE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 105.89% +0.01pp
- Institutions
- 620
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund79.97%
Hedge Fund13.14%
Public Company5.14%
Private Company2.79%
Government Pension Fund2.37%
Individual/Insider1.47%
Sovereign Wealth Fund1.26%
Insurance Company0.59%
Family Office/Trust0.53%
Top holders as of 2026-06-30
BlackRock
11.40% · 1.48M sh
AQR Capital Management
7.42% · 965.92K sh
Vanguard Portfolio Management, LLC
6.05% · 787.07K sh
Vanguard Capital Management, LLC
5.29% · 688.38K sh
Acadian Asset Management LLC
3.48% · 453.24K sh
State Street Global Advisors
3.42% · 444.72K sh
Geode Capital Management, LLC
3.18% · 413.94K sh
J.P. Morgan Asset Management, Inc.
2.84% · 369.59K sh
Boston Partners Global Investors, Inc.
2.16% · 280.68K sh
Dimensional Fund Advisors
2.00% · 260.56K sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 23 buys · 27 sells
| Name | Role | Stake |
|---|---|---|
| Thomas Hutton | Officer | 0.62% |
| Kevin McNamara | Chief Executive Officer | 0.51% |
| Spencer Lee | Executive Vice President | 0.11% |
| Michael Witzeman | Vice President | 0.05% |
| Andrea Lindell | Independent Director | 0.04% |
| George Walsh | Independent Chairperson | 0.03% |
| Patrick Grace | Independent Director | 0.03% |
| Brian Judkins | VP, Secretary & Chief Legal Officer | 0.03% |
| Christopher Heaney | Independent Director | 0.02% |
| Ron DeLyons | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Spencer Lee | Executive Vice President | Derivative Exercise and Sale | -11,160 | $445.35–508.93 |
| 2026-09-29 | Spencer Lee | Executive Vice President | Derivative Exercise and Retained | +939 | $445.35 |
| 2026-09-27 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $513.45 |
| 2026-09-27 | Thomas Hutton | Officer | Derivative Exercise and Sale | -4,270 | $445.35–506.65 |
| 2026-09-27 | Thomas Hutton | Officer | Derivative Exercise and Retained | +359 | $445.35 |
| 2026-09-17 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $501.40 |
| 2026-08-20 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $541.16 |
| 2026-08-20 | Spencer Lee | Executive Vice President | Open Market Disposition | -1,000 | $541.04 |
| 2026-08-09 | Brian Judkins | VP, Secretary & Chief Legal Officer | Derivative Exercise and Sale | -5,878 | $445.35–548.96 |
| 2026-08-09 | Brian Judkins | VP, Secretary & Chief Legal Officer | Derivative Exercise and Retained | +908 | $445.35 |
| 2026-08-04 | Joel Wherley | President & CEO of VITAS Healthcare | Derivative Exercise and Sale | -2,270 | $445.35–542.62 |
| 2026-08-04 | Joel Wherley | President & CEO of VITAS Healthcare | Derivative Exercise and Retained | +329 | $445.35 |
| 2026-08-02 | Kevin McNamara | Chief Executive Officer | Open Market Disposition | -2,000 | $539.51 |
| 2026-07-30 | Kevin McNamara | Chief Executive Officer | Sale to Issuer | -17,801 | $529.22 |
| 2026-07-30 | Kevin McNamara | Chief Executive Officer | Derivative Exercise and Sale | -2,001 | $445.35–529.22 |
| 2026-07-30 | Patrick Grace | Independent Director | Open Market Disposition | -190 | $532.00 |
| 2026-06-08 | Andrea Lindell | Independent Director | Open Market Disposition | -1,347 | $447.33 |
| 2026-05-28 | George Walsh | Independent Chairperson | Open Market Disposition | -500 | $437.83 |
| 2026-05-17 | Patrick Grace | Independent Director | Other Acquisition | +386 | $440.77 |
| 2026-05-17 | George Walsh | Independent Chairperson | Other Acquisition | +386 | $440.77 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:24:31 · For reference only, not investment advice and not tailored to your situation.